For instance, the FDA approved Eli Lillys Zepbound (tirzepatide) for chronic weight management in late 2023, accelerating nationwide adoption and setting the pace for GLP-1 innovation
Hemphill III, J
But the shortage has since ended, and the pharmacies have continued to make their own versions, under laws that allow them to make drugs for specific patients
I've always had really high highs and really low lows, and I think at the time, maybe everybody was like, Oh, it's temper tantrums, when it was hormones. Although always active during school, playing basketball, running cross-country and swimming in the off-season, I just could not do anything but gain weight, Hamilton said
J Aerosol Med Pulm Drug Deliv 33(4):171177 Vilcins D, Cortes-Ramirez J, Currie D, Preston P (2021) Early environmental exposures and life-long risk of chronic non-respiratory disease
That's why we like, you know, some of these scans where if someone doesn't have a wearable, and then ultimately what do you do with it